News
-
-
-
COMMUNIQUÉ DE PRESSE
Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million
Biotest AG reports 4.5% revenue growth in first 9 months, reaching Euro 523 million. Product sales rise by 13.7%. Adjusted EBIT remains stable. Marketing authorization application submitted for Fibrinogen Concentrate (BT524). Outlook adjusted -
COMMUNIQUÉ DE PRESSE
Aurubis AG: Aurubis investing € 40 million in more independent and efficient production in Lünen
Aurubis AG invests €40 million in constructing an air separation unit at the Lünen plant, aiming for more independent and efficient production. The ASU will reduce CO2 emissions and enhance oxygen production -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Singulus Technologies AG (von NuWays AG): Hold
Singulus Technologies AG released solid Q3 results with sales up 44% driven by Life Science and Semiconductor segments. EBIT at €0.6m, order intake increased 126% yoy. Company still needs above €95m sales for sustainability
